SIGA Technologies (SIGA) logo

SIGA Technologies (SIGA) stock

Worth $208M

After-hours
$2.80
0.00%

Close $2.80 +2.56%

Why SIGA fell 16% since Nov 9

Down 16% from Nov 9 to Nov 17 while the S&P 500 fell 3%.

  • Its Nov 9 results: total revenues were $1.3M, from $2.6M a year before. It fell 4% on Nov 10.

Sources: Price history, Nov 17, 2026; Company release, Nov 9, 2026

Tell me next time SIGA moves

Free account, no card. An optional alert when SIGA moves or its score changes.Pro, 7 days free with a card. An optional alert when SIGA moves or its score changes.

Or see it live, free until Friday morning. No account.
1 more reason, free with an account →1 more reason why SIGA fell 16% since Nov 9, from its filings, with the other side, the timeline, and its peers, for Pro members.
Quality Score
-3
Poor
In its industry
#71of 89
Checks firing
4of 14
Choppy
From 52-week high
-60.6%
under its best in a year

SIGA's Quality Score rose 2 points on Wed, Nov 18, to -3.

Follow SIGA's trial news. Pro members can get an alert when SIGA Technologies files news, and see its trials, share raises, and its CEO's filings.

Get an alert when SIGA files news on its trialSee it live, free until Friday morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Cash$116M in cash. One of the last four quarters brought cash in while the others used it.On Sep 30

Key facts on SIGA

Key facts on SIGA
Since its 2022 highDown 90% profit $33.9M → $686,200 a year
Latest filing8-K, Nov 9 Reported its quarterly results
1 more reason behind SIGA's -3, free with an account →4 more reasons behind SIGA's -3, for Pro members.

SIGA in the news

Tue Nov 10SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026 SEC filing 4:05 PM ET · GlobeNewswire SIGA closed −4.0% that day.

Cash$116M in cash. One of the last four quarters brought cash in while the others used it.On Sep 30

SIGA catalysts

Coming up

After its last 4 reports it closed -2.0% on average, higher 1 of 4 times.

4 past catalysts since 2022, with sizes and sources, for Pro members.

What's next for SIGA, and how long its cash lasts

Its trials

A trial underway
Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSPhase 2 · Active · 100 people · main data estimated Jan 1, 2027 · NCT04957485

For Pro members: 28 filings.

Cash runway Sep 30 balance sheet

$116M in cash

One of the last four quarters brought cash in while the others used it, so an average says little about the next.

What it means: a runway is counted only when each of the last four quarters used cash.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Diem Nguyen’s 9 filings and quotes.

Get an alert when SIGA files news on its trialA free account. No card.Pro, 7 days free with a card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

12 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 149 dates, ranked →

Why SIGA scores -3

Poorfor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means

  • +4Chart checks 4 of 14 firing right now, one point each
  • −3Long-term trend below a falling 200-⁠day average, down over one year, down over two years
  • Size subtracts
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth subtractsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
  • Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Run-up, Dilution, Persistence, and News.

What every line is worth, and the reason behind it, on SIGA and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 7:41 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How SIGA ranks in Pharma

SIGA is #71 of 89 by Quality Score.

How SIGA ranks in Pharma
RankStockQuality Score
71SIGA Technologies (SIGA) logoSIGASIGA Technologies-3

More in Pharma

When does SIGA report earnings, and what happens after?

Expected to report Tue Mar 9, after the close (in 111 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What SIGA reported on Nov 9, 2026

The quarter

A loss of $0.04 a share.

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

Where the quarter's sales came from
LineQ3
2026
Q2
2026
Q3
2025
By product
Research and Developmentdown 37%$1.1M82%$3.1M8%$1.7M66%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 9)

1 more line, for Pro members.

The outlook

No outlook figures read from this release.

The numbers

Market value
$208M
today
Sales
$52.4M
down 69.6% on the year

Sales fell 5.4% a year over 5 years, fiscal 2020 to 2025.

Its share count fell 2% a year over 5 years.

3 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on SIGA: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

+1.5%-2.2%-4.0%
May 7Aug 6Nov 9
ReportedGapReaction5
days
Nov 9, 2026After close-6.8%-4.0%-12.6%
Aug 6, 2026After close+1.0%-2.2%-7.7%
May 7, 2026After close-2.0%+1.5%-9.9%

SIGA closed higher after 1 of its last 4 reports.

All 4 reports, and SIGA's Quality Score going into each

SIGA sales and profit by year

Sales and profit by year

Sales grew in three of the last seven years, to $94.6M in 2025. It made a profit in seven of the eight years.

SIGA has 4 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on SIGA, and all 14 on every stock.Get in free →

SIGA RSI today: 40.7, below its 50-day and 200-day averages

Not scored

RSI 40.7, MACD below signal, below both averages. Not scored.

The deep dive on SIGA

7 more findings on SIGA, each with its source, for Pro members.

SIGA's officers and directors

Officers and directors with a Form 4 in the last 12 months.

3 more officers and directors file at SIGA.

See insider trades by person

Which ETFs hold SIGA?

In ETFs: SIGA is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About SIGA Technologies

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

49 employeesNew York, NYsiga.com

What SIGA Technologies says it competes with

“The biotechnology and pharmaceutical industries are characterized by rapidly evolving technology and intense competition.”

From its annual report, SEC filing · Mar 10, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on SIGA and every other stock.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn SIGA's score around: 8 things
  • 2 more filings explained, a plain line each
  • Real-⁠time prices, no delay
See SIGA's 14 chart checks

See it live, free until Friday morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 18, 2026: SIGA's Quality Score is -3 (Poor), #71 of 89 in Pharma.

What does SIGA's Quality Score say?

SIGA scores -3 today, which Breakaway calls Poor. It is #71 of 89 in Pharma by Quality Score, with 4 of 14 chart checks firing. Down 16% from Nov 9 to Nov 17 while the S&P 500 fell 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is SIGA's Quality Score?

SIGA scores -3 today, which Breakaway calls Poor (below zero). That is #71 of 89 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SIGA's -3.

When does SIGA report earnings?

Expected to report Tue Mar 9, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. SIGA closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,147 stocks ranked

See it live, free until Friday morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.

What's next for SIGA Technologies: from its SEC filings and ClinicalTrials.gov, the company's words, the registry's dates, and arithmetic, not a forecast. Companies often miss the dates they set.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.